KEGG pathway examination suggested substantial enrichment in pathways encompassing pathways in cancer, PI3K/Akt signaling, EGFR tyrosine kinase inhibitor resistance, endocrine resistance, and central carbon metabolism in cancer (Figure 2B). This evidence concerns the gene AKT1 and cancer.